Ultrasound Hair Growth Treatment Alma TED: The Two-Pass Acoustic Delivery Protocol Explained
More than 80 million Americans experience hair loss, with androgenetic alopecia specifically affecting 50 million men and 30 million women across the United States. This prevalence has created a crowded landscape of hair loss treatments, ranging from pharmaceutical interventions to surgical restoration. Among the growing options, needle-free, non-invasive treatments hold particular appeal for patients seeking effective solutions without the discomfort or downtime associated with injections or surgery.
The ultrasound hair growth treatment Alma TED represents a significant advancement in this non-invasive category. TransEpidermal Delivery (TED) technology goes far beyond the typical marketing pitch of “painless and needle-free.” This patented system employs two distinct biophysical mechanisms—acoustic cavitation and directional air pressure—to deliver growth-promoting compounds directly to hair follicles at depths that topical applications alone cannot reach.
This article provides a comprehensive explanation of how Alma TED works, walking through the precise two-pass protocol step by step while offering an honest assessment of the current evidence base. Hair Transplant Specialists, a practice with board-certified surgeons holding over 100 combined years of experience in hair restoration, offers deeper-than-average clinical insight into this technology as part of their comprehensive treatment portfolio.
What Is Alma TED? Beyond the ‘Needle-Free’ Headline
TransEpidermal Delivery (TED) is a patented, non-invasive hair restoration technology protected under US Patent No. US 10,238,849 B2. Alma TED is not a laser, not a microneedling device, and not a PRP injection. Instead, it uses low-frequency acoustic sound waves combined with air pressure to deliver a growth-promoting serum into the scalp without breaking the skin.
The device holds FDA clearance as a Class I medical device—the lowest risk classification—for treating androgenetic alopecia in both men and women. Clinicians also use it off-label for other hair loss types, including stress-induced shedding and diffuse thinning.
Two components make the treatment work: the acoustic delivery device itself and the TED+ Hair Care Formula serum. Understanding that two distinct biophysical processes operate during treatment—not one—is essential for setting realistic expectations about outcomes.
The Scalp as a Barrier: Why Getting Actives In Is the Core Challenge
The stratum corneum—the outermost layer of skin—presents the primary obstacle to topical hair loss treatments. This layer features a “brick and mortar” lipid bilayer structure specifically designed to keep foreign substances out. While excellent for protection, this barrier effectively blocks large molecules like peptides and growth factors—precisely the ingredients most beneficial to hair follicles.
Hair follicles sit 3–5 millimeters below the skin surface, making topical-only application of growth factors largely ineffective without a delivery mechanism capable of penetrating the stratum corneum. This barrier problem represents the central engineering challenge that Alma TED’s two-pass protocol is designed to solve.
The Two Biophysical Mechanisms: How Alma TED Actually Works
Most descriptions of Alma TED conflate two separate mechanisms into one vague “ultrasound opens channels” explanation. A clear understanding requires examining each mechanism independently.
Mechanism 1: Acoustic Cavitation and Lipid Bilayer Disruption
Acoustic cavitation occurs when low-frequency ultrasonic waves cause microscopic gaseous bubbles within the stratum corneum to rapidly expand and collapse. At the cellular level, the mechanical energy from these collapsing bubbles temporarily disorganizes the lipid bilayer—the tightly packed lipid matrix between skin cells—creating transient, reversible microchannels.
These microchannels are not permanent wounds. The skin barrier restores itself within hours, which is why the treatment causes no lasting damage. Research has established that low-frequency ultrasound (LFS) is significantly more effective at cavitation-mediated permeabilization than high-frequency ultrasound, explaining why the first pass uses a lower frequency setting.
The first FDA-approved LFS device for transdermal delivery (lidocaine) received clearance in 2004, establishing the foundational regulatory precedent for this approach.
Mechanism 2: The Air Pressure Pushback Effect
The second, less-discussed mechanism involves the patented TED device tip, engineered to generate a directional air pressure “pushback effect.” While the acoustic waves create microchannels, the air pressure component actively drives the TED+ serum through those channels and into the sub-epidermal layers. This functions as a pressurized delivery system rather than relying on passive diffusion.
The distinction matters: cavitation opens the door; the air pressure pushback effect pushes the serum through it. Passive diffusion of large molecules through even temporarily disrupted skin is slow and incomplete. The directional pressure ensures active ingredients reach the depth of the hair bulb (3–5 mm below the surface).
This dual-mechanism approach—acoustic cavitation plus directional air pressure—distinguishes Alma TED from generic ultrasound devices or simple topical serums. Patients typically experience a warm, vibrating sensation similar to a scalp massage during treatment, and some may hear a mild ringing or buzzing sound caused by the acoustic waves, which resolves immediately after treatment.
The TED+ Hair Care Formula: What Goes In and Why It Matters
The delivery mechanism represents only half the equation. The TED+ Hair Care Formula, developed by a world-renowned research lab and formulated specifically to work with the TED delivery system, contains several key ingredient categories:
- Peptides: Signal proteins that stimulate follicular activity
- Growth factors: Promote cell proliferation and follicular regeneration
- Vitamins: Support scalp health and reduce oxidative stress
- Synergistic actives: Additional compounds that enhance overall efficacy
This standardized, pre-formulated serum offers a clinical advantage over PRP. PRP concentration and growth factor content varies significantly based on the patient’s own blood health, age, and platelet count, while TED+ delivers a consistent, reproducible dose every session.
The formula supports follicular strength, reduces shedding, improves hair shaft diameter, and promotes new growth—addressing multiple aspects of the hair loss cycle simultaneously. One limitation worth noting: the specific proprietary concentrations of each ingredient are not publicly disclosed by Alma Lasers, making independent ingredient-level analysis difficult.
The Two-Pass Treatment Protocol: A Step-by-Step Walkthrough
Understanding the precise sequence of events during an Alma TED session helps patients know exactly what to expect. The two passes represent distinct phases with different objectives, not simply two repetitions of the same action.
Before the Session Begins: Assessment and Preparation
The pre-treatment assessment includes evaluation of the patient’s scalp condition, hair loss pattern (Norwood scale for men, Ludwig scale for women), and treatment area. The scalp is typically cleansed to remove oils, product buildup, and debris that could impede acoustic wave transmission or serum absorption.
No anesthesia, numbing cream, or topical preparation is required—a key differentiator from microneedling or PRP. Patients should arrive with clean, dry hair and no styling products for optimal results. Total session time runs approximately 20–45 minutes depending on the size of the treatment area.
Pass One: The Priming Pass — Opening the Barrier
During the first pass, the clinician moves the TED handpiece systematically across the treatment area using a defined grid or zone-based pattern to ensure complete coverage. This pass uses a lower-frequency ultrasound setting optimized for acoustic cavitation.
The goal is to temporarily disorganize the lipid bilayer and create transient microchannels throughout the stratum corneum. Patients experience a warm, vibrating sensation as the device moves slowly and methodically across the scalp—no pain, just mild warmth.
During this phase, the stratum corneum is being “primed”: its normally impenetrable lipid matrix becomes temporarily permeable, creating a window of enhanced absorption. The second pass and serum application must follow promptly while the microchannels remain open. No serum is applied during the first pass, which focuses purely on barrier preparation.
Serum Application: Introducing the TED+ Formula
Following the priming pass, the TED+ Hair Care Formula is applied directly to the treatment area while the stratum corneum microchannels remain open. The quantity and distribution of serum application is standardized to ensure consistent coverage across the treatment zone.
The growth factors, peptides, and vitamins in the formula are now positioned at the entrance of the temporary microchannels, ready to be driven deeper during the second pass.
Pass Two: The Delivery Pass — Driving the Formula Deep
The clinician again moves the TED handpiece across the same treatment area, this time with the TED+ serum present on the scalp surface. The second pass uses a higher-frequency setting—the goal shifts from cavitation-mediated barrier disruption to active mechanical transport of the serum through the open microchannels.
The directional air pressure from the device tip works in concert with the acoustic waves to actively push the serum through the microchannels and into the sub-epidermal layers where hair follicles reside. The sensation remains similar—warm and vibrating—though the mild ringing or buzzing sound (if heard) is most noticeable during this phase due to the higher frequency setting.
The combination of open microchannels and active pressure delivery allows the formula to reach the hair bulb level (3–5 mm depth)—far deeper than any topical application could achieve through passive diffusion alone.
After the Session: Immediate Post-Treatment Experience
Most patients show no redness, swelling, or visible signs of treatment immediately after the session. The skin barrier begins restoring itself within hours.
Standard post-care instructions include:
- Avoid washing hair for 24 hours to allow continued absorption
- Avoid strenuous exercise for 24 hours, as sweat can dilute the serum
- Wait at least 24 hours before dyeing or chemically treating hair
Patients can return to normal activities immediately. Some report a mild tingling sensation in the scalp for a short period after treatment, which resolves quickly.
The Standard Treatment Series: Protocol, Timing, and Maintenance
The standard initial series consists of three sessions spaced approximately 30 days apart. Monthly spacing allows the follicular response cycle to progress between treatments.
Timeline of results:
- Reduced shedding is often noticed within the first few weeks
- Visible improvements in hair density typically appear 3–6 months after beginning treatment
- Peak results are usually evident 6–12 months after completing the initial series
Results are not permanent without ongoing treatment. Maintenance sessions every 6–12 months are necessary to sustain improvements. Androgenetic alopecia is a chronic, progressive condition driven by ongoing DHT sensitivity and genetic factors. Alma TED addresses the delivery of supportive actives but does not alter the underlying genetic cause.
Hair Transplant Specialists follows this standard protocol: a series of three treatments one month apart, with maintenance every 6–12 months. Alma TED can also be combined with minoxidil, finasteride, PRP, PDGF (Platelet-Derived Growth Factor), or exosome therapy for enhanced results, and can be used post-hair transplant to support healing and graft survival.
What the Clinical Evidence Actually Shows
An honest evidence review requires contextualizing both favorable findings and their limitations.
Key Clinical Study Results
- Study 1 (N=31; 29F, 2M): Three treatments resulted in a 23% increase in hair density at one month post-treatment and 31% at six months; no pain or adverse events were reported.
- Study 2 (N=50): 98% of patients reported reduced shedding, 96% noted increased hair growth, 89% observed visible improvement in hair density, and 100% expressed high satisfaction.
- Desai (2023) white paper: Overall hair density improved 27% at 90 days in female pattern hair loss and 22% in male pattern hair loss after three TED sessions 30 days apart; no pain or adverse events were reported.
Honest Caveats: What the Evidence Base Cannot Yet Tell Us
Most clinical data specific to Alma TED is manufacturer-funded (Alma Lasers)—a meaningful limitation that patients and clinicians should understand. Large-scale, independent, randomized controlled trials (RCTs) specifically for Alma TED remain absent.
The distinction matters: the broader science of sonophoresis and low-frequency ultrasound-mediated transdermal delivery is well-supported in peer-reviewed literature, and the mechanism is not in question. The specific clinical outcomes for this device, however, require more independent validation.
Individual results vary based on degree of hair loss, age, hormonal status, and adherence to maintenance protocols. A clinician who explains evidence limitations is more trustworthy than one who presents only favorable marketing data.
Who Is (and Is Not) a Good Candidate for Alma TED
Ideal candidates include:
- Men and women with early to moderate androgenetic alopecia
- Those experiencing stress-induced shedding (postpartum, post-illness telogen effluvium)
- Individuals with general diffuse thinning
- Those seeking a non-invasive complement to other treatments
Alma TED works by enhancing the environment around existing follicles and delivering growth-supporting actives. It cannot regenerate follicles that are completely gone, making completely bald individuals with no remaining vellus hair unsuitable candidates.
Contraindications include:
- Active scalp infections or open wounds
- History of trigeminal neuralgia
- Active scalp psoriasis or eczema in the treatment area
- Pregnancy (insufficient safety data)
- Implanted electronic devices near the treatment area
A thorough consultation with a qualified hair restoration specialist is essential to determine candidacy.
How Alma TED Compares to Other Non-Surgical Hair Loss Treatments
Alma TED vs. PRP (Platelet-Rich Plasma)
PRP requires a blood draw, centrifugation, and scalp injections. Alma TED requires none of these. PRP growth factor concentration varies with patient health, age, and platelet count, while the TED+ formula delivers a standardized, consistent dose every session. Both can be combined for potentially enhanced results.
Alma TED vs. Surgical Hair Transplant (FUE/FUT)
Alma TED and hair transplant surgery address fundamentally different problems. Hair transplant surgery (FUE or FUT) permanently relocates living follicles from donor to recipient areas—the only permanent solution for significant hair loss. Alma TED supports existing follicles and cannot restore areas of complete follicular loss.
Alma TED is appropriate for early-to-moderate thinning; surgical transplant is appropriate for moderate-to-advanced loss with sufficient donor supply. Alma TED can be used post-transplant to support graft survival and scalp recovery.
What to Expect at Hair Transplant Specialists: The Alma TED Experience
Hair Transplant Specialists offers comprehensive consultations that include hair loss assessment, scalp evaluation, review of medical history and current treatments, and development of a personalized treatment plan. The clinical team—including Dr. Sharon Keene, former ISHRS President, and board-certified colleagues—brings surgical-level expertise to non-surgical treatment planning.
The practice offers Alma TED as part of a comprehensive non-surgical portfolio that also includes PRP, exosome therapy, LLLT, finasteride, and minoxidil, allowing for combination protocols tailored to individual needs. Their facility in Eagan, Minnesota, provides a patient-centered approach that prioritizes the individual’s treatment journey.
Conclusion: A Clinically Honest Assessment of Ultrasound Hair Growth Treatment
Alma TED employs two distinct biophysical mechanisms: acoustic cavitation disrupts the lipid bilayer to create transient microchannels during the first pass, while the air pressure pushback effect drives the TED+ serum through those channels to follicular depth during the second pass. The underlying science of low-frequency sonophoresis is well-established in peer-reviewed literature.
Device-specific clinical data is promising but largely manufacturer-funded and based on small studies. Independent large-scale RCTs are still needed. Alma TED represents a well-engineered, non-invasive option for early-to-moderate hair thinning that complements—but does not replace—proven treatments like minoxidil, finasteride, LLLT, or surgical restoration for appropriate candidates.
The best outcomes come from a comprehensive, personalized approach developed with a qualified hair restoration specialist.
Ready to Find Out If Alma TED Is Right for You?
Scheduling a consultation at Hair Transplant Specialists provides access to a personalized hair loss assessment from a board-certified hair restoration specialist. The consultation evaluates not just whether Alma TED is appropriate, but what combination of treatments—surgical or non-surgical—best fits each patient’s specific pattern, stage, and goals.
Contact Information:
- Phone: (651) 393-5399
- Location: 2121 Cliff Dr. Suite 210, Eagan, MN 55122
- Hours: Monday–Thursday 9AM–5PM, Friday 9AM–3PM, weekends by appointment
Hair Transplant Specialists offers the full range of non-surgical and surgical hair restoration options to address every stage of hair loss.
